Intellia Therapeutics, Inc. · NASDAQ:NTLA
The Vanguard Group reported a 11.23% stake in Intellia Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 11.23% stake in Intellia Therapeutics, Inc., 13,010,001 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 11.23%
- Shares
- 13,010,001
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 11.23% | 13,010,001 |
Source
Related
- Intellia Therapeutics, Inc.
- The Vanguard Group
- Intellia Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · The Vanguard Group · Jan 8, 2025
- Form 4 · Dube Michael P · Oct 6, 2026
- Form 4 · Leonard John M · Aug 24, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Dulac Edward J III · Jul 24, 2026
- Form 4 · Dulac Edward J III · Jul 6, 2026